SH2D4A can compete with PLCG and bind to ESR1, inhibiting estrogen induced cell proliferation, blocking the effect of estrogen on PLCG, and inhibiting estrogen induced proliferation. It may play a role in the development and function of T cells. SH2D4A is abnormally expressed in certain cancers.
